azathioprine has been researched along with Thromboembolism, Venous in 4 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sirolimus (rapamycin) is a potent anti-proliferative agent with immunosuppressive properties that is increasingly being used in solid-organ and hematopoietic stem cell transplantation." | 6.76 | Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. ( Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; DeOliveira, NC; Durazo-Arvizu, R; Garrity, E; Krishnan, JA; Love, RB; McShane, PJ; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT, 2011) |
| "Sirolimus (rapamycin) is a potent anti-proliferative agent with immunosuppressive properties that is increasingly being used in solid-organ and hematopoietic stem cell transplantation." | 2.76 | Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. ( Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; DeOliveira, NC; Durazo-Arvizu, R; Garrity, E; Krishnan, JA; Love, RB; McShane, PJ; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, W | 1 |
| Shim, HH | 1 |
| Ng, SC | 1 |
| Liu, J | 1 |
| Inglis, C | 1 |
| Greveson, K | 1 |
| Baraty, B | 1 |
| Haifer, C | 1 |
| Leong, RWL | 1 |
| Thorell, SE | 1 |
| Gorodkin, R | 1 |
| Murray, D | 1 |
| Thachil, J | 1 |
| Bollen, L | 1 |
| Vande Casteele, N | 1 |
| Ballet, V | 1 |
| van Assche, G | 1 |
| Ferrante, M | 1 |
| Vermeire, S | 1 |
| Gils, A | 1 |
| Ahya, VN | 1 |
| McShane, PJ | 1 |
| Baz, MA | 1 |
| Valentine, VG | 1 |
| Arcasoy, SM | 1 |
| Love, RB | 1 |
| Seethamraju, H | 1 |
| Garrity, E | 1 |
| Alex, CG | 1 |
| Bag, R | 1 |
| DeOliveira, NC | 1 |
| Vigneswaran, WT | 1 |
| Charbeneau, J | 1 |
| Krishnan, JA | 1 |
| Durazo-Arvizu, R | 1 |
| Norwick, L | 1 |
| Bhorade, S | 1 |
1 trial available for azathioprine and Thromboembolism, Venous
| Article | Year |
|---|---|
Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
Topics: Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; | 2011 |
3 other studies available for azathioprine and Thromboembolism, Venous
| Article | Year |
|---|---|
A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas.
Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Diarrhea; Directive Counseling; Endemic Diseases; G | 2018 |
Behcet's disease and refractory thrombosis.
Topics: Anticoagulants; Azathioprine; Behcet Syndrome; Drug Therapy, Combination; Female; Humans; Immunosupp | 2015 |
Thromboembolism as an important complication of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; C | 2016 |